Watchlist Price Alert

INmune Bio Inc. (INMB)

NASDAQ: INMB · Real-Time Price · USD

6.87

-1.15 (-14.34%)

At close: Jun 17, 2025, 3:59 PM

INmune Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-42.08M	-30.01M	-27.3M	-30.34M	-12.1M	-7.68M	-12.44M	-831.49K	-277.49K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	7.61M	7.37M	7.15M	4.8M	3.11M	4.1M	10M	199.56K	n/a
Other Working Capital	1.38M	1.7M	-4.27M	-5.35M	-1.03M	-129.21K	-134.38K	-218.81K	-309.95K
Other Non-Cash Items	79K	224K	328K	126K	3.19M	-1.54M	9.81M	-150K	50K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.04M	10.44M	-2.86M	-3.09M	43.51K	-260.88K	379.67K	20.1K	-89.89K
Operating Cash Flow	-33.36M	-11.98M	-22.69M	-28.5M	-8.94M	-5.38M	-2.06M	-761.83K	-317.38K
Capital Expenditures	n/a	n/a	n/a	-15M	n/a	n/a	n/a	-100K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-15M	n/a	n/a	n/a	-100K	n/a
Investing Cash Flow	n/a	n/a	n/a	-15M	n/a	n/a	n/a	-100K	n/a
Debt Repayment	-10M	-5M	n/a	14.95M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-1.01M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	30K	1.15M	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	18.21M	-4.22M	729K	96.36M	23.89M	12.21M	900K	2.06M	450K
Net Cash Flow	-14.93M	-16.3M	-22.66M	52.84M	14.97M	6.81M	-1.18M	1.23M	129.78K
Free Cash Flow	-33.36M	-11.98M	-22.69M	-43.5M	-8.94M	-5.38M	-2.06M	-861.83K	-317.38K